RecruitingNot ApplicableNCT06170541

CORE-COMPARE Pilot Study

Ultra-High Resolution Computed Tomography (CT) vs. Conventional CT for Detecting Obstructive Coronary Artery Disease (CAD) The CORE-COMPARE Pilot Study


Sponsor

Johns Hopkins University

Enrollment

140 participants

Start Date

Apr 5, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The utility of Ultra High-Resolution Computed Tomography (UHR-CT) compared to conventional CT in all-comers (i.e., a generally lower-risk population) remains uncertain but is an important area of study in order to justify wider spread implementation and use of this technology, particularly in light of reports of significantly higher radiation exposure with UHR-CT, as well as longer scan times. The availability of technology to reconstruct conventional resolution (CR) simulation images from the raw CT acquisition data acquired on the UHR-CT scanner offers a unique platform to study this question without subjecting individuals to two different scans. The primary objective of this study is to generate preliminary data in support of the hypothesis that noninvasive UHR-CT is superior to conventional resolution CT for identifying patients with obstructive CHD.


Eligibility

Min Age: 21 YearsMax Age: 85 Years

Inclusion Criteria4

  • Patients aged 21-85 years
  • Clinical history suggestive of CHD who are referred by their primary cardiologist for further evaluation via Computed tomography angiography (CTA) will be asked to participate.
  • Women of child bearing potential must demonstrate a negative pregnancy test within 24 hours of the study CTA.
  • Ability to understand and willingness to sign the Informed Consent Form.

Exclusion Criteria9

  • Known allergy to iodinated contrast media.
  • History of multiple myeloma or previous organ transplantation
  • Elevated serum creatinine (\> 1.5mg/dl) OR calculated creatinine clearance of \< 60 ml/min (using the Cockcroft-Gault formula
  • Atrial fibrillation or uncontrolled tachyarrhythmia, or advanced atrioventricular block (second or third degree heart block)
  • Evidence of severe symptomatic heart failure (NYHA Class III or IV);
  • Known or suspected moderate or severe aortic stenosis
  • History of prior percutaneous coronary intervention (PCI) in one or more vessel or history of coronary arterial bypass grafting (CABG)
  • Suspected acute coronary syndrome
  • Presence of any other history or condition that the investigator feels would be problematic

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAquilion Precision

Ultra-High Resolution CT (UHR CT) capable of resolving anatomy as small as 150 microns, providing CT image quality with resolution typically seen only in cath labs. The UHR detector is newly designed to provide more than twice the resolution when compared with today's CT technology, with an all-new detector as well as tube, gantry and reconstruction technologies.

DEVICEConventional Computed Tomography

Conventional reconstruction Computed Tomography (CT) represents a pivotal approach in medical imaging.


Locations(1)

Johns Hopkins School of Medicine

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06170541


Related Trials